SpectaCell
A life sciences company developing a next-generation cell analysis platform for drug development and manufacturing.
SpectaCell is a biotech & life sciences company based in Ghent, BE, founded in 2026. It has raised $6.72 million in disclosed funding. Its latest round was a Seed of €6 million in October 2026.
Overview
No overview yet. It is written from sources once there are enough of them.
Funding
Total disclosed: $6.7M across 1 round. Computed only from sourced rounds.
| Date | Company | Amount | Stage | Lead | Other investors | Sector | Sources |
|---|---|---|---|---|---|---|---|
| €6M | Seed | imec.xpand | PMV +3 | Biotech & Life Sciences | 1 |
- SpectaCell€6M
Led by imec.xpand · with PMV, +3
Investors
Questions and answers
What does SpectaCell do?
A life sciences company developing a next-generation cell analysis platform for drug development and manufacturing.
How much has SpectaCell raised?
SpectaCell has raised $6.72 million in disclosed funding across 1 round tracked by OSH.
Who has invested in SpectaCell?
Investors in SpectaCell include imec.xpand, PMV, InnovationQuarter Capital, Qbic, and VIB.
When and where was SpectaCell founded?
SpectaCell was founded in 2026 and is based in Ghent, BE.
Timeline
Founded
Sources
- 1.Ghent-based SpectaCell launches with €6 million to advance its cell analysis platform for immunotherapy development — EU-Startups, Oct 9, 2026